Table 4.
Clinical features of patients with papillary thyroid cancer by group in patients with and without Hashimoto’s thyroiditis (HT)
| Characteristics |
Group I |
Group II |
χ2 | P-value |
|---|---|---|---|---|
|
(with HT) |
(without HT) |
|||
| n = 187 | n = 817 | |||
| Age, yr |
|
|
7.298 |
0.063 |
| <30 |
23 (12.3) |
65 (8.0) |
|
|
| 30~44 |
76 (40.6) |
362 (44.3) |
|
|
| 45~59 |
74 (39.6) |
291 (35.6) |
|
|
| >60 |
14 (7.5) |
99 (12.1) |
|
|
| Gender |
|
|
35.082 |
<0.001* |
| Male |
5 (2.7) |
171 (20.9) |
|
|
| Female |
182 (97.3) |
646 (79.1) |
|
|
| Thyroid-associated disorders |
|
|
3.322 |
0.325 |
| Nodular goiter |
56 (81.2) |
258 (82.2) |
|
|
| Follicular adenoma |
8 (11.6) |
45 (14.3) |
|
|
| Graves disease |
4 (5.8) |
10 (3.2) |
|
|
| Malignant lymphoma | 1 (1.4) | 1 (0.3) |
Results are presented as number (%) of patients. *Statistically significant (P < 0.05).